SUE HOUX: Open Payments
NPI 1457465072 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 14 payments from 6 companies in 2025. Trend: 2023 $175 · 2024 $153 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $156 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| ABIOMED | 1 | $29 |
| Exact Sciences Corporation | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Ozempic, AIRSUPRA, Wegovy, Cologuard Collection Kit, Rybelsus, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
